IS8141A - Makrólíðsamrunaefnasambönd með bólgueyðandi virkni - Google Patents

Makrólíðsamrunaefnasambönd með bólgueyðandi virkni

Info

Publication number: IS8141A
Authority: IS; Iceland
Prior art keywords: inflammatory activity; macrolide conjugates; macrolide; conjugates; inflammatory
Prior art date: 2003-04-24

Application number

IS8141A

Other languages

English (en)

Other versions

IS2736B (is

Inventor

Mercep Mladen

Mesic Milan

Tomaskovic Linda

Markovic Stribor

Hrvacic Boska

Makaruha Oresta

Poljak Visnja

Original Assignee

Pliva - Istrazivacki Institut D.O.O.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-24

Filing date

2005-11-22

Publication date

2005-11-22

2005-11-22 Application filed by Pliva - Istrazivacki Institut D.O.O. filed Critical Pliva - Istrazivacki Institut D.O.O.

2005-11-22 Publication of IS8141A publication Critical patent/IS8141A/is

2011-06-15 Publication of IS2736B publication Critical patent/IS2736B/is

Links

230000003110 anti-inflammatory effect Effects 0.000 title 1
239000003120 macrolide antibiotic agent Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Genetics & Genomics (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

IS8141A 2003-04-24 2005-11-22 Makrólíðsamrunaefnasambönd@með@bólgueyðandi@virkni IS2736B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HR20030324A HRP20030324A2 (en)	2003-04-24	2003-04-24	Compounds of antiinflammatory effect
PCT/IB2004/001235 WO2004094449A1 (en)	2003-04-24	2004-04-23	Macrolide-conjugates with anti-inflammatory activity

Publications (2)

Publication Number	Publication Date
IS8141A true IS8141A (is)	2005-11-22
IS2736B IS2736B (is)	2011-06-15

Family

ID=33307078

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS8141A IS2736B (is)	2003-04-24	2005-11-22	Makrólíðsamrunaefnasambönd@með@bólgueyðandi@virkni
IS8941A IS8941A (is)	2003-04-24	2010-12-29	Efnasambönd með bólgueyðandi virkni

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IS8941A IS8941A (is)	2003-04-24	2010-12-29	Efnasambönd með bólgueyðandi virkni

Country Status (27)

Country	Link
US (1)	US7579334B2 (is)
EP (2)	EP1633771B1 (is)
JP (1)	JP4613366B2 (is)
KR (1)	KR101107336B1 (is)
CN (1)	CN100393741C (is)
AR (1)	AR044083A1 (is)
AT (1)	ATE518876T1 (is)
AU (1)	AU2004232546B2 (is)
BR (1)	BRPI0410490A (is)
CA (1)	CA2523081C (is)
CL (1)	CL2004000872A1 (is)
CY (2)	CY1109491T1 (is)
DE (1)	DE602004022047D1 (is)
DK (2)	DK1633771T3 (is)
ES (2)	ES2370371T3 (is)
HR (3)	HRP20030324A2 (is)
IS (2)	IS2736B (is)
ME (1)	MEP34708A (is)
MX (1)	MXPA05011359A (is)
NO (2)	NO333909B1 (is)
PL (2)	PL1633771T3 (is)
PT (2)	PT2070940E (is)
RS (1)	RS52621B (is)
RU (1)	RU2355699C2 (is)
SI (2)	SI2070940T1 (is)
WO (1)	WO2004094449A1 (is)
ZA (1)	ZA200508388B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200420573A (en)	2002-09-26	2004-10-16	Rib X Pharmaceuticals Inc	Bifunctional heterocyclic compounds and methods of making and using same
HRP20030324A2 (en)	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect
US8202843B2 (en)	2004-02-27	2012-06-19	Rib-X Pharmaceuticals, Inc.	Macrocyclic compounds and methods of making and using the same
EP1778292A2 (en) *	2004-08-12	2007-05-02	GlaxoSmithKline istrazivacki centar Zagreb d.o.o.	Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
US20060183696A1 (en) *	2004-08-12	2006-08-17	Pliva-Istrazivacki Institut D.O.O.	Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
ES2337915T3 (es) *	2004-10-27	2010-04-30	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Conjugados con adtividad antiinflamatoria.
TW201900217A (zh)	2005-12-22	2019-01-01	美商海卓勒生物科學公司	用於調節ｔｒｐａ１功能之化合物
WO2007093840A2 (en) *	2006-02-15	2007-08-23	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
BRPI0909030A2 (pt) *	2008-03-05	2018-03-13	Panacea Biotec Ltd	composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.
CN102838660B (zh) *	2011-06-23	2016-11-02	上海市第一人民医院	一种抑制炎症免疫反应的小肽及其应用
EP2948152A4 (en) *	2013-01-23	2016-12-14	Sphaera Pharma Private Ltd	NOVEL COMPOUNDS OF 11-BETA HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES RELATED TO MITOCHONDRIA DYSFUNCTION OR ADDITIONAL
JP2016510753A (ja) *	2013-03-08	2016-04-11	アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ	ステロイド薬と結合した抗生物質共役体
RU2015138891A (ru)	2013-03-08	2017-04-11	Аллерган, Инк.	Конъюгаты антибиотиков, напрямую связанные со стероидными препаратами
US20140256666A1 (en) *	2013-03-08	2014-09-11	Allergan, Inc.	Antibiotic conjugates with nonsteroidal anti-inflammatory drugs
EP2964269A1 (en)	2013-03-08	2016-01-13	Allergan, Inc.	Cyclosporine a-steroid conjugates
CN106714770B (zh)	2014-07-23	2024-04-19	斯法尔制药私人有限公司	羟基类固醇化合物、其中间体、制备方法、组合物及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3779221D1 (de)	1986-08-19	1992-06-25	Genentech Inc	Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
DE3860503D1 (de) *	1987-09-03	1990-10-04	Pliva Pharm & Chem Works	10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
SE9100342D0 (sv)	1991-02-04	1991-02-04	Astra Ab	Novel steroid esters
SE9100341D0 (sv)	1991-02-04	1991-02-04	Astra Ab	Novel steroids
GB9225923D0 (en)	1992-12-11	1993-02-03	Rhone Poulenc Rorer Ltd	New compositions of matter
CA2149777C (en)	1992-12-24	2004-05-25	Michael John Ashton	New steroids
CA2196879A1 (en)	1994-08-12	1996-02-22	Akihiko Hoshino	Interleukin-5 production inhibitor
WO1996004920A1 (en)	1994-08-12	1996-02-22	Taisho Pharmaceutical Co., Ltd.	Interleukin-5 production inhibitor
DE19616573C2 (de)	1996-04-25	1999-03-04	Pari Gmbh	Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
JP3530004B2 (ja)	1998-02-06	2004-05-24	株式会社日立ユニシアオートモティブ	吸入式投薬器
JP2002528495A (ja)	1998-10-30	2002-09-03	ニトロメドインコーポレーテッド	ニトロソ化およびニトロシル化された非ステロイド抗炎症性化合物、組成物および使用方法
IT1306205B1 (it)	1999-01-15	2001-05-30	Zambon Spa	Macrolidi ad attivita' antiinfiammatoria.
HRP20000310A2 (en)	2000-05-17	2002-02-28	Pliva Farmaceutska Ind Dioniko	New dibenzoazulene compounds as tumor necrosis factor inhibitors
FI110835B (fi)	2000-07-11	2003-03-31	Radiolinja Ab	Menetelmä palvelunumeropuhelun tarjoamiseksi matkaviestintilaajalle ennalta määrätyllä taksalla
HRP20010018A2 (en)	2001-01-09	2002-12-31	Pliva D D	Novel anti-inflammatory compounds
EP1483579A4 (en)	2002-02-15	2006-07-12	Merckle Gmbh	CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS FOR THE PREPARATION AND USE OF CONJUGATES, FORMULATION AND PHARMACEUTICAL APPLICATIONS OBTAINED FROM SUCH CONJUGATES
US20040186063A1 (en)	2002-02-15	2004-09-23	Hans-Jurgen Gutke	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
NZ535354A (en)	2002-02-15	2008-01-31	Merckle Gmbh	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003264917A1 (en)	2002-07-08	2004-01-23	Pliva - Istrazivacki Institut D.O.O.	Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
US7109176B2 (en)	2002-07-08	2006-09-19	Pliva-Istrazivacki Institut D.O.O.	Nonsteroidal anti-inflammatory substances, compositions and methods for their use
JP4790263B2 (ja)	2002-07-08	2011-10-12	グラクソグループリミテッド	炎症性の疾患および病態を治療する新規な化合物、組成物および方法
HRP20030324A2 (en)	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect

2003
- 2003-04-24 HR HR20030324A patent/HRP20030324A2/hr not_active Application Discontinuation
2004
- 2004-04-22 US US10/830,858 patent/US7579334B2/en not_active Expired - Fee Related
- 2004-04-23 PT PT09075145T patent/PT2070940E/pt unknown
- 2004-04-23 ES ES09075145T patent/ES2370371T3/es not_active Expired - Lifetime
- 2004-04-23 AU AU2004232546A patent/AU2004232546B2/en not_active Ceased
- 2004-04-23 DK DK04729157T patent/DK1633771T3/da active
- 2004-04-23 CL CL200400872A patent/CL2004000872A1/es unknown
- 2004-04-23 KR KR1020057020252A patent/KR101107336B1/ko not_active Expired - Fee Related
- 2004-04-23 JP JP2006506511A patent/JP4613366B2/ja not_active Expired - Fee Related
- 2004-04-23 PT PT04729157T patent/PT1633771E/pt unknown
- 2004-04-23 RS YU20050873A patent/RS52621B/sr unknown
- 2004-04-23 RU RU2005131937/04A patent/RU2355699C2/ru not_active IP Right Cessation
- 2004-04-23 EP EP04729157A patent/EP1633771B1/en not_active Expired - Lifetime
- 2004-04-23 WO PCT/IB2004/001235 patent/WO2004094449A1/en not_active Ceased
- 2004-04-23 EP EP09075145A patent/EP2070940B1/en not_active Expired - Lifetime
- 2004-04-23 AR ARP040101400A patent/AR044083A1/es unknown
- 2004-04-23 CN CNB2004800110487A patent/CN100393741C/zh not_active Expired - Fee Related
- 2004-04-23 HR HR20090551T patent/HRP20090551T1/hr unknown
- 2004-04-23 MX MXPA05011359A patent/MXPA05011359A/es active IP Right Grant
- 2004-04-23 DE DE602004022047T patent/DE602004022047D1/de not_active Expired - Lifetime
- 2004-04-23 DK DK09075145.4T patent/DK2070940T3/da active
- 2004-04-23 ES ES04729157T patent/ES2330109T3/es not_active Expired - Lifetime
- 2004-04-23 CA CA2523081A patent/CA2523081C/en not_active Expired - Lifetime
- 2004-04-23 ME MEP-347/08A patent/MEP34708A/xx unknown
- 2004-04-23 PL PL04729157T patent/PL1633771T3/pl unknown
- 2004-04-23 SI SI200431768T patent/SI2070940T1/sl unknown
- 2004-04-23 PL PL09075145T patent/PL2070940T3/pl unknown
- 2004-04-23 BR BRPI0410490-0A patent/BRPI0410490A/pt not_active Application Discontinuation
- 2004-04-23 AT AT09075145T patent/ATE518876T1/de active
- 2004-04-23 SI SI200431253T patent/SI1633771T1/sl unknown
2005
- 2005-10-17 ZA ZA200508388A patent/ZA200508388B/xx unknown
- 2005-11-22 IS IS8141A patent/IS2736B/is unknown
- 2005-11-23 NO NO20055535A patent/NO333909B1/no not_active IP Right Cessation
2009
- 2009-10-14 CY CY20091101070T patent/CY1109491T1/el unknown
2010
- 2010-12-29 IS IS8941A patent/IS8941A/is unknown
2011
- 2011-10-19 HR HR20110763T patent/HRP20110763T1/hr unknown
- 2011-10-25 CY CY20111101008T patent/CY1111978T1/el unknown
2013
- 2013-06-28 NO NO20130898A patent/NO335552B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP4613366B2 (ja)	2011-01-19
HRP20110763T1 (hr)	2011-11-30
NO20130898L (no)	2006-01-16
HK1086842A1 (zh)	2006-09-29
RU2005131937A (ru)	2006-06-27
EP2070940B1 (en)	2011-08-03
PT2070940E (pt)	2011-11-14
RU2355699C2 (ru)	2009-05-20
KR20060024770A (ko)	2006-03-17
CA2523081A1 (en)	2004-11-04
EP1633771B1 (en)	2009-07-15
RS52621B (sr)	2013-06-28
SI2070940T1 (sl)	2011-12-30
ZA200508388B (en)	2006-07-26
NO335552B1 (no)	2014-12-29
MEP34708A (en)	2011-05-10
AR044083A1 (es)	2005-08-24
HK1129681A1 (en)	2009-12-04
HRP20030324A2 (en)	2005-02-28
ES2370371T3 (es)	2011-12-14
US20050080003A1 (en)	2005-04-14
IS2736B (is)	2011-06-15
HRP20090551T1 (hr)	2010-01-31
NO20055535L (no)	2006-01-16
KR101107336B1 (ko)	2012-01-19
CY1111978T1 (el)	2015-11-04
MXPA05011359A (es)	2006-05-12
IS8941A (is)	2010-12-29
NO20055535D0 (no)	2005-11-23
EP1633771A1 (en)	2006-03-15
AU2004232546B2 (en)	2011-06-09
CY1109491T1 (el)	2014-08-13
CL2004000872A1 (es)	2005-03-18
DE602004022047D1 (de)	2009-08-27
PL1633771T3 (pl)	2009-12-31
PT1633771E (pt)	2009-10-20
SI1633771T1 (sl)	2009-12-31
JP2006524221A (ja)	2006-10-26
WO2004094449A8 (en)	2005-03-31
EP2070940A3 (en)	2009-11-25
ATE518876T1 (de)	2011-08-15
WO2004094449A1 (en)	2004-11-04
BRPI0410490A (pt)	2006-06-13
DK1633771T3 (da)	2009-11-16
ES2330109T3 (es)	2009-12-04
RS20050873A (sr)	2007-08-03
CA2523081C (en)	2010-08-03
CN1777619A (zh)	2006-05-24
PL2070940T3 (pl)	2011-12-30
AU2004232546A1 (en)	2004-11-04
CN100393741C (zh)	2008-06-11
NO333909B1 (no)	2013-10-14
EP2070940A1 (en)	2009-06-17
US7579334B2 (en)	2009-08-25
DK2070940T3 (da)	2011-10-31

Publication	Publication Date	Title
FR17C1054I2 (fr)	2019-01-11	Conjugues de type vecteur-derive de calicheamicine
DE602004031807D1 (de)	2011-04-28	Tragestruktur
IS8941A (is)	2010-12-29	Efnasambönd með bólgueyðandi virkni
IS8403A (is)	2006-04-07	Pýrrólafleiður með bakteríueyðandi virkni
DE602004025366D1 (de)	2010-03-18	Koaxialen Katheter
DK1594840T3 (da)	2007-02-05	Piperidin-benzensulfonamid-derivater
DE602004017700D1 (de)	2008-12-24	Transmukosen verabreichung
MA29108B1 (fr)	2007-12-03	Macrolides
ATE352550T1 (de)	2007-02-15	Chinazolinderivate
ATE420066T1 (de)	2009-01-15	Amidoacetonitrilderivate
ATE395345T1 (de)	2008-05-15	Imidazol-4-yl-ethynyl-pyridin-derivate
DK1685131T3 (da)	2007-07-09	Hydroxyalkylsubstituerede pyrido-7-pyrimidin-7-oner
ATE354365T1 (de)	2007-03-15	N-thiazol-2-yl-benzamid-derivate
FI20031679L (fi)	2005-05-20	Työnnin
DE602004026145D1 (de)	2010-05-06	Rippenstruktur
ATE449064T1 (de)	2009-12-15	Amidoacetonitrilderivate
NO20034599L (no)	2005-04-15	Brokonstruksjon
EP1698330A4 (en)	2012-08-15	EXTERNAL ANALGESIC ANTI-INFLAMMATORY PREPARATION
DK1691814T3 (da)	2012-10-29	Antiinflammatoriske midler
NO20034600D0 (no)	2003-10-14	Brokonstruksjon
EP1697515A4 (en)	2008-02-06	DNA CARRIER CONJUGATE
FR2851150B3 (fr)	2005-01-07	Structure de grille-pain
ITMI20051329A1 (it)	2007-01-14	Macrolidi ad attivita' antiinfiammatoria
ES1055359Y (es)	2004-03-01	Pieza de construccion
UA9218S (uk)	2004-08-16	Хрест із розп`яттям